Total Payments
$7,189
2024 Payments
$1,066
Companies
37
Transactions
303
Medicare Patients
6,762
Medicare Billing
$841,415
Payment Breakdown by Category
Food & Beverage$6,573 (91.4%)
Travel$428.93 (6.0%)
Education$187.48 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,573 | 299 | 91.4% |
| Travel and Lodging | $428.93 | 1 | 6.0% |
| Education | $187.48 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $776.48 | 61 | $0 (2024) |
| PFIZER INC. | $583.29 | 35 | $0 (2024) |
| ABIOMED | $543.66 | 2 | $0 (2019) |
| Amgen Inc. | $537.89 | 26 | $0 (2024) |
| Abbott Laboratories | $415.51 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $379.80 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $363.97 | 15 | $0 (2024) |
| ASAHI INTECC USA, INC. | $357.49 | 4 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $340.64 | 19 | $0 (2024) |
| Medtronic Vascular, Inc. | $332.39 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,066 | 67 | PFIZER INC. ($187.93) |
| 2023 | $977.34 | 56 | Novartis Pharmaceuticals Corporation ($297.45) |
| 2022 | $1,115 | 63 | PFIZER INC. ($163.60) |
| 2021 | $1,294 | 65 | Amgen Inc. ($312.63) |
| 2020 | $249.36 | 6 | Medtronic USA, Inc. ($152.43) |
| 2019 | $1,474 | 16 | ABIOMED ($543.66) |
| 2018 | $762.23 | 24 | Medtronic Vascular, Inc. ($204.01) |
| 2017 | $250.55 | 6 | Medtronic Vascular, Inc. ($107.78) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.59 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $18.94 | General |
| 11/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.93 | General |
| 11/04/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $14.90 | General |
| Category: Coronary | ||||||
| 10/28/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $32.04 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.08 | General |
| 09/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.88 | General |
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: Cardiovascular | ||||||
| 09/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/09/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.74 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.92 | General |
| Category: Cardiovascular | ||||||
| 08/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| Category: Cardiovascular | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,336 | 3,331 | $1.1M | $269,167 |
| 2022 | 33 | 2,428 | 3,806 | $1.3M | $341,846 |
| 2021 | 20 | 1,810 | 2,226 | $858,888 | $204,915 |
| 2020 | 5 | 188 | 188 | $122,790 | $25,487 |
Total Patients
6,762
Total Services
9,551
Medicare Billing
$841,415
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 356 | 358 | $336,520 | $61,438 | 18.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 195 | 388 | $126,100 | $39,344 | 31.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 459 | 477 | $108,040 | $27,711 | 25.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 171 | 180 | $108,000 | $26,470 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 258 | $64,500 | $25,819 | 40.0% |
| 99493 | Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes | Office | 2023 | 24 | 135 | $68,985 | $16,930 | 24.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 45 | 271 | $60,433 | $12,841 | 21.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 62 | 236 | $40,120 | $10,197 | 25.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 45 | 45 | $45,000 | $8,683 | 19.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 90 | 103 | $23,175 | $6,985 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $21,250 | $5,805 | 27.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 34 | 160 | $21,600 | $5,545 | 25.7% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 20 | 20 | $8,820 | $3,801 | 43.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 24 | 26 | $13,000 | $2,360 | 18.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 45 | 45 | $11,250 | $2,058 | 18.3% |
| 99494 | Psychiatric collaborative care management per calendar month, each additional 30 minutes | Office | 2023 | 13 | 36 | $7,020 | $1,844 | 26.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $7,225 | $1,782 | 24.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 142 | 145 | $11,600 | $1,694 | 14.6% |
| 99492 | Initial psychiatric collaborative care management, first calendar month, first 70 minutes | Office | 2023 | 11 | 11 | $5,643 | $1,480 | 26.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 17 | 17 | $6,381 | $1,029 | 16.1% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 12 | 12 | $4,050 | $964.62 | 23.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 43 | 43 | $9,675 | $936.18 | 9.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 90 | 99 | $5,999 | $689.04 | 11.5% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 18 | 18 | $3,600 | $622.80 | 17.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 25 | 27 | $4,725 | $574.02 | 12.1% |
About Dr. Amish Patel, MD
Dr. Amish Patel, MD is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1083938906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amish Patel, MD has received a total of $7,189 in payments from pharmaceutical and medical device companies, with $1,066 received in 2024. These payments were reported across 303 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,573).
As a Medicare-enrolled provider, Patel has provided services to 6,762 Medicare beneficiaries, totaling 9,551 services with total Medicare billing of $841,415. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Student in an Organized Health Care Education/Training Program
- Location Pasadena, CA
- Active Since 03/22/2010
- Last Updated 10/16/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083938906
Products in Payments
- Impella (Device) $543.66
- Repatha (Biological) $523.23
- ENTRESTO (Drug) $455.26
- XARELTO (Drug) $379.80
- JARDIANCE (Drug) $363.97
- ELIQUIS (Drug) $363.67
- ASAHI PTCA Guide Wire (Device) $357.49
- LifeVest (Device) $340.64
- LEQVIO (Drug) $321.22
- OPSUMIT (Drug) $269.78
- VYNDAQEL (Drug) $255.72
- FARXIGA (Drug) $204.24
- NEXLETOL (Drug) $192.05
- CAMZYOS (Drug) $178.39
- Solitaire (Device) $152.43
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $147.39
- DALVANCE (Drug) $125.00
- Mitra Clip system (Device) $125.00
- Ozempic (Drug) $111.27
- ROTABLATOR (Device) $102.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882